Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 3092Neoplasms 2436Carcinoma, Non-Small-Cell Lung 1863Prostatic Neoplasms 1617Colorectal Neoplasms 1422Lung Neoplasms 1292Multiple Myeloma 927Neoplasm Metastasis 919Leukemia, Myeloid, Acute 874Pancreatic Neoplasms 847Ovarian Neoplasms 799Melanoma 783Carcinoma, Hepatocellular 736Stomach Neoplasms 639Brain Neoplasms 635Recurrence 633Squamous Cell Carcinoma of Head and Neck 630Head and Neck Neoplasms 609Glioblastoma 566Lymphoma 539Uterine Cervical Neoplasms 537Triple Negative Breast Neoplasms 504Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Carcinoma, Renal Cell 497Hematologic Neoplasms 462Urinary Bladder Neoplasms 459Endometrial Neoplasms 459Colonic Neoplasms 441Lymphoma, Non-Hodgkin 435Sarcoma 434

Interventions

Fecal Microbiota Transplantation 2Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Solid Carcinoma × 1 year × Clear all
NCT04264975 2026-05-22

Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology

Asan Medical Center

Phase NA Recruiting
60 enrolled

Solid Carcinoma

NCT06051214 2026-02-17

THROMBIN

Institut Cancerologie de l'Ouest

Phase NA Recruiting
200 enrolled

Solid Carcinoma

NCT05533983 2025-12-03

NIVO-FMT

Asan Medical Center

Phase NA Recruiting
50 enrolled

Solid Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡